![Xing Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Xing Zhao formerly worked at Trilogy Global Advisors LP, as Investment Analyst.
Mr. Zhao received his graduate degree in 2007 from The Trustees of Columbia University in The City of New York.
Anciens postes connus de Xing Zhao
| Sociétés | Poste | Fin |
|---|---|---|
Trilogy Global Advisors LP
 Trilogy Global Advisors LP Investment ManagersFinance Trilogy Global Advisors primarily provides discretionary portfolio management regarding US and non-US equity securities. The firm generally invests companies they believe show sustainable earnings power and are either traditional or early-stage growth companies. Trilogy offers the following portfolio strategies: Global Equity, Global Concentrated Equity, Global Select Equity, International Equity, International Small Cap Equity, Emerging Markets Equity and Emerging Wealth Equity. They may manage some portfolios following other equity, debt or balanced investment strategies, but generally do not actively offer these strategies on an on-going basis. Trilogy employs a multi-step quantitative stock screening process to assist in portfolio construction. They rely primarily on internally or externally generated models to construct investment portfolios. Trilogy also purchases and/or receives research data and software from third parties to support their research process. Trilogy’s Global Equity, Global Concentrated Equity, Global Select Equity, Emerging Wealth and International Equity strategies generally look for companies with more than $1 billion in market-cap and companies with a debt to equity ratio of greater than 75%, excluding financials. Trilogy’s International Small Cap Equity strategy generally eliminates companies with less than $300 million and greater than $4 billion in market-cap and companies with a debt to total capital ratio of greater than 60%. Trilogy’s Emerging Markets strategy conducts a separate screening process that generally eliminates companies with less than $750 million in market-cap and companies with a debt to total capital ratio of greater than 60% and looks for projected revenue growth. Companies that pass this screen are combined with emerging markets stocks from the Global strategy list. For the Emerging Wealth strategy, Trilogy's' global sector analysts generally identify developed market companies with more than 20% of revenues originating in emerging markets and/or a substantial part of earnings growth driven from emerging markets. Emerging market companies with material revenues from developed markets are generally eliminated unless research determines future growth will be driven by emerging markets. | Analyst-Equity | - |
Formation de Xing Zhao
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Trilogy Global Advisors LP
Trilogy Global Advisors LP Investment ManagersFinance Trilogy Global Advisors primarily provides discretionary portfolio management regarding US and non-US equity securities. The firm generally invests companies they believe show sustainable earnings power and are either traditional or early-stage growth companies. Trilogy offers the following portfolio strategies: Global Equity, Global Concentrated Equity, Global Select Equity, International Equity, International Small Cap Equity, Emerging Markets Equity and Emerging Wealth Equity. They may manage some portfolios following other equity, debt or balanced investment strategies, but generally do not actively offer these strategies on an on-going basis. Trilogy employs a multi-step quantitative stock screening process to assist in portfolio construction. They rely primarily on internally or externally generated models to construct investment portfolios. Trilogy also purchases and/or receives research data and software from third parties to support their research process. Trilogy’s Global Equity, Global Concentrated Equity, Global Select Equity, Emerging Wealth and International Equity strategies generally look for companies with more than $1 billion in market-cap and companies with a debt to equity ratio of greater than 75%, excluding financials. Trilogy’s International Small Cap Equity strategy generally eliminates companies with less than $300 million and greater than $4 billion in market-cap and companies with a debt to total capital ratio of greater than 60%. Trilogy’s Emerging Markets strategy conducts a separate screening process that generally eliminates companies with less than $750 million in market-cap and companies with a debt to total capital ratio of greater than 60% and looks for projected revenue growth. Companies that pass this screen are combined with emerging markets stocks from the Global strategy list. For the Emerging Wealth strategy, Trilogy's' global sector analysts generally identify developed market companies with more than 20% of revenues originating in emerging markets and/or a substantial part of earnings growth driven from emerging markets. Emerging market companies with material revenues from developed markets are generally eliminated unless research determines future growth will be driven by emerging markets. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
